The Oxford Classification of IgA nephropathy (IgAN) is the most widely accepted system for assessing histologic findings in IgAN. A new publication refines this classification by adding a crescent score, reassessing the segmental sclerosis score, and contextualizing the clinical relevance of the histologic lesions.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
Trials Open Access 25 May 2022
-
The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study
BMC Nephrology Open Access 21 January 2022
-
Immunofluorescence deposits in the mesangial area and glomerular capillary loops did not affect the prognosis of immunoglobulin a nephropathy except C1q:a single-center retrospective study
BMC Nephrology Open Access 29 January 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Moriyama, T. et al. Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS ONE 9, e91756 (2014).
Cattran, D. C. et al. The Oxford classification of IgA nephropathy: rationale, clinicopathologic correlations, and classification. Kidney Int. 76, 534–545 (2009).
Roberts, I. S. D. et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 76, 546–556 (2009).
Trimarchi, H. et al. Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int. 91, 1014–1021 (2017).
Tumlin, J. A. & Hennigar, R. A. Clinical presentation, natural history, and treatments of crescentic proliferative IgA nephropathy. Semin. Nephrol. 24, 256–268 (2004).
Avasare, R. S. et al. Predicting post-transplant recurrence of IgA nephropathy: the importance of crescents. Am. J. Nephrol. 45, 99–106 (2017).
Lv, J. et al. Evaluation of the Oxford classification of IgA nephropathy: a systemic review and meta-analysis. Am. J. Kidney Dis. 62, 891–899 (2013).
Haas, M. et al. A multicenter study of the predictive value of crescents in IgA nephropathy. J. Am. Soc. Nephrol. 28, 691–701 (2017).
Barbour, S. J. et al. The MEST score provides earlier risk prediction in IgA nephropathy. Kidney Int. 9, 167–175 (2016).
Bellur, S. S. et al. Evidence from the Oxford classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy. Kidney Int. 91, 235–243 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Markowitz, G. Updated Oxford Classification of IgA nephropathy: a new MEST-C score. Nat Rev Nephrol 13, 385–386 (2017). https://doi.org/10.1038/nrneph.2017.67
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2017.67
This article is cited by
-
Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
Trials (2022)
-
The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study
BMC Nephrology (2022)
-
Immunofluorescence deposits in the mesangial area and glomerular capillary loops did not affect the prognosis of immunoglobulin a nephropathy except C1q:a single-center retrospective study
BMC Nephrology (2021)
-
Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis
Clinical and Experimental Nephrology (2021)
-
Enhanced Bruton’s tyrosine kinase activity in the kidney of patients with IgA nephropathy
International Urology and Nephrology (2021)